Palantir Technologies has clawed back ground this week, up 0.9% to $133.25, but the recovery looks tentative against a peer group that has sold off harder — and one analyst just broke ranks to end a bearish call.
The most interesting move this week came from Wolfe Research, which upgraded PLTR from Underperform to Peer Perform on June 16. That is a capitulation, not a buy signal — Wolfe is simply stepping back from an active bear case rather than making a bullish argument. The broader analyst picture remains cautious. The formal consensus is a hold, and the distribution reflects the disagreement: Rosenblatt and Wedbush both carry targets of $225-$230, nearly 70% above the current price. RBC's Rishi Jaluria holds firm at $90 and Underperform. The average price target of $185 sits well above $133, but that gap reflects a split Street rather than conviction — with the consensus as of March 2026 now stale enough that it may not fully reflect post-earnings sentiment. The valuation makes the debate harder to resolve: at a P/E of 76x and EV/EBITDA of 55.6x, both down modestly over the past month, PLTR still commands a premium that demands sustained execution. Bulls point to AI demand, high margins, and defence contract insulation; bears flag commoditisation risk, founder-controlled governance, and a stock that has now sold off after each of its last two earnings beats.
The lending market offers no particular drama. Borrow availability is extraordinarily loose — over 8,000% relative to shares already short — meaning there is essentially no friction for new short sellers. Cost to borrow is running at 0.42%, close to unchanged on the week and still well below 1%. Short interest, at 3.0% of the free float, has drifted about 2.5% higher over the past week but remains a modest position overall. This is not a crowded short. Options positioning reinforces the point: the put/call ratio has eased to 0.93, roughly 1.4 standard deviations below its 20-day average of 0.98. After the post-earnings defensive rotation documented in prior coverage, options traders have now turned slightly more tilted toward calls than usual. That shift is a change from the cautious posture of two weeks ago, but at less than one-sigma, it doesn't signal conviction in either direction.
Insider flow tells the background story on sentiment. CEO Alex Karp sold $2.3m of stock on May 20. CFO David Glazer sold $1.3m the same day. The Chief Legal Officer and Chief Accounting Officer also sold on that date. The 90-day net position across all insiders is a net sale of roughly $121m in value terms, though the net share count is slightly positive at 887,000 shares — a quirk that likely reflects vesting mechanics rather than buying conviction. None of these trades carry high significance scores, and the programme-sale pattern is consistent with long-running 10b5-1 plans. Still, no executive has bought on the open market during the post-earnings pullback — a quiet signal in itself.
Against peers, PLTR's modest week stands out as relative strength. GWRE fell 5.7% and ZETA dropped 6.4%. NOW lost 5.3% and PCOR fell 8.6%. APP held up comparably, down just 1.1% — but the group as a whole has continued to slide while PLTR has found a tentative foothold near $133. Whether that reflects genuine relative strength or simply less room to fall after the company already repriced sharply in early June is the open question. The pattern from prior earnings — a pre-print run, a sell-off despite a beat, and a slow grind back toward the prior range — is holding. The next earnings print is due August 3, and the window between now and then will test whether the $130-$135 area can hold as a base or becomes a staging ground for another round of pre-event positioning.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
